Omega-3 fatty acids and dyslipidemic agent for lipid therapy

Omega-3 fatty acids and dyslipidemic agent for lipid therapy

  • CN 101,098,690 A
  • Filed: 11/22/2005
  • Published: 01/02/2008
  • Est. Priority Date: 12/06/2004
  • Status: Active Application
First Claim
Patent Images

1. the method for a lipid therapy, it comprises uses dyslipidemic agent and the pharmaceutical composition natural or synthetic omega-fatty acid or the acceptable ester of its pharmacy, derivant, conjugate, precursor or salt or its mixture that comprises effective dose to the patient, wherein said patient'"'"'s baseline triglyceride levels is 200 to 499mg/dl, and wherein said patient is after administration, compare with the described dyslipidemic agent treatment of independent use, patient'"'"'s triglyceride levels and non-HDL-C level have reduced, and the LDL-C level does not increase.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×